Quick Takeaways
- Ran Nussbaum has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $28,989,859.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Ran Nussbaum
- Location
- Santa Monica, CA
- Summary
- The estimated net worth of Ran Nussbaum is at least $28,989,859 dollars as of 16 Sep 2025. Ran Nussbaum is the Director of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $26.75M. Ran Nussbaum is the Director, 10%+ Owner of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $2.24M.
- Signature
- /s/ Marc Panoff, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ran Nussbaum and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: UroGen Pharma Ltd. ($26,747,876).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ran Nussbaum
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | Director | $26,747,876 | 21 Oct 2022 | ||
| KROS | Keros Therapeutics, Inc. | Director, 10%+ Owner | $2,241,983 | 04 Jun 2025 | ||
| ELOX | Eloxx Pharmaceuticals, Inc. | Director | 15 Jun 2022 | |||
| LBRX | LB PHARMACEUTICALS INC | Director | 12 Sep 2025 |
Insider Transactions Reported by Ran Nussbaum:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.